Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Comparison of capillary blood and plasma samples for the evaluation of seroprevalence to SARS-CoV-2 antibodies by lateral flow immunoassay in a university population in Medellín, Colombia, 2020.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101774776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5352 (Electronic) Linking ISSN: 26665352 NLM ISO Abbreviation: Public Health Pract (Oxf) Subsets: PubMed not MEDLINE
    • Publication Information:
      Original Publication: [Oxford] : Elsevier Ltd., [2020]-
    • Abstract:
      Objectives: The aim of this study was to estimate the seroprevalence of anti-SARS-CoV-2 antibodies using the SARS-CoV-2 antibody test in a university population. Capillary blood and plasma samples were compared and correlated with symptomatology to establish rapid treatment processes and develop a public health strategy within the community.
      Study Design: Descriptive study of seroprevalence of anti-SARS-CoV-2 antibodies in a university population.
      Methods: Standardised and validated laboratory serological tests were used to assess the immune response detected in capillary blood and plasma samples. In this study, 280 participants from the University Colegio Mayor de Antioquia in the Municipality of Medellín, Colombia, were tested for SARS-CoV-2 antibodies in capillary blood and plasma samples between November 2020 and January 2021.
      Results: In total, 29 (11.2%) individuals had positive results for anti-SARS-CoV-2 antibodies (IgG/IgM); 28 (96.6%) had positive results in plasma samples and 11 (37.9%) in capillary blood samples. The two tests were compared, and the overall sensitivity and specificity of capillary vs plasma samples was 36.7% and 99.6%, respectively.
      Conclusions: Anti-SARS-CoV-2 antibodies (IgG/IgM) can be used to estimate the seroprevalence in populations, including immunity by vaccination; however, capillary blood samples should not be used to detect previous infection as they provide low sensitivity compared to plasma samples.
      Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
      (© 2022 Published by Elsevier Ltd on behalf of The Royal Society for Public Health.)
    • References:
      Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. (PMID: 32221519)
      West J Emerg Med. 2020 Apr 13;21(3):470-472. (PMID: 32302278)
      Science. 2021 Jan 8;371(6525):126-127. (PMID: 33414210)
      Ann Intern Med. 2020 Sep 15;173(6):450-460. (PMID: 32496919)
      J Clin Virol. 2020 Aug;129:104529. (PMID: 32659710)
      Clinics (Sao Paulo). 2020 Jun 03;75:e2013. (PMID: 32520228)
      J Clin Virol. 2020 Aug;129:104455. (PMID: 32485618)
      Nat Commun. 2020 Sep 17;11(1):4704. (PMID: 32943637)
      medRxiv. 2020 May 17;:. (PMID: 32511497)
    • Contributed Indexing:
      Keywords: COVID-19; Predictive values; Sensitivity and specificity; Youden statistic
    • Publication Date:
      Date Created: 20221220 Latest Revision: 20230102
    • Publication Date:
      20240104
    • Accession Number:
      PMC9751005
    • Accession Number:
      10.1016/j.puhip.2022.100347
    • Accession Number:
      36536854